Trial Profile
Clinical Trials Insight: 700023140
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 May 2007
Price :
$35
*
At a glance
- Drugs ICT 107 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- Sponsors ImmunoCellular Therapeutics
- 14 May 2007 New trial record.